During the past decade, Orchid Life Department, Orchid Pharmed Company conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orchid Life Department, Orchid Pharmed Company" #1 collaborator was "Vaxine Pty Ltd" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Orchid Life Department, Orchid Pharmed Company" are "COVID-19" (2 trials). Many other conditions were trialed in "Orchid Life Department, Orchid Pharmed Company" in a lesser frequency.

Most popular intervention types in "Orchid Life Department, Orchid Pharmed Company" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant" (2 trials), "Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant" (1 trials) and "Saline placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orchid Life Department, Orchid Pharmed Company" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Orchid Life Department, Orchid Pharmed Company". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Orchid Life Department, Orchid Pharmed Company, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orchid Life Department, Orchid Pharmed Company, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".